World Health Organization, 2018. Leprosy - Registered Cases Per 10 000 Population Data by Country. Available at: http://apps.who.int/gho/data/node.main.NTDLEPR4?lang=en. Accessed July 17, 2019.)| false
U.S. Census Bureau. American FactFinder, 2018. American Community Survey 5-year Population Estimates. Available at: https://data.census.gov/cedsci/table?q=arkansas&tid=ACSDP5Y2017.DP05&hidePreview=false. Accessed November 15, 2019.)| false
U.S. Department of Health and Human, 2015. A Summary of Hansen’s Disease in the United States-2014. Available at: https://www.hrsa.gov/sites/default/files/hansensdisease/pdfs/hansens2014report.pdf. Accessed October 25, 2019.)| false
Arkansas Department of Health, 2019. Arkansas Department of Health (ADH) Mandatory Reportable Diseases List and Instructions. Available at: https://www.healthy.arkansas.gov/images/uploads/pdf/List_and_Instructions_Reportable_Diseases.pdf. Accessed October 24, 2019.)| false
National Hansen’s Disease Program, 2015. Instructions for Completing the Hansen’s Disease (Leprosy) Surveillance Form. Available at: https://www.hrsa.gov/sites/default/files/hrsa/hansens-disease/pdfs/hansen-disease-surveillance-form.pdf. Accessed October 25, 2019.)| false
PocaterraL, JainS, ReddyR, MuzaffarullahS, TorresO, SuneethaS, LockwoodDNJ, 2006. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg74: 868–879.
PocaterraLJainSReddyRMuzaffarullahSTorresOSuneethaSLockwoodDNJ, 2006. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India. Am J Trop Med Hyg74: 868–879.)| false
Persons from the Republic of the Marshall Islands have among the highest rates of Hansen’s disease (HD) in the world; the largest Marshallese community in the continental United States is in northwest Arkansas. In 2017, the HD Ambulatory Care Clinic in Springdale, Arkansas, informed the Arkansas Department of Health (ADH) that Marshallese persons with HD had severe disease with frequent complications. To characterize their illness, we reviewed ADH surveillance reports of HD among Marshallese persons in Arkansas treated during 2003–2017 (n = 42). Hansen’s Disease prevalence among Marshallese in Arkansas (11.7/10,000) was greater than that in the general U.S. population. Complications included arthritis (38%), erythema nodosum leprosum (21%), and prolonged treatment lasting > 2 years (40%). The majority (82%) of patients treated for > 2 years had documented intermittent therapy. Culturally appropriate support for therapy and adherence is needed in Arkansas.
Address correspondence to Sarah M. Labuda, Division of Scientific Education and Professional Development, Epidemic Intelligence Service, Centers for Disease Control and Prevention, Arkansas Department of Health, 4815 West Markham St., Slot 32, Little Rock, AR 72205. E-mail: firstname.lastname@example.org
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC or the Arkansas Department of Health.